Plasma Branched-Chain and Aromatic Amino Acids in Relation to Hypertension

• Published in: Nutrients 2020-12, Vol.12 (12), p.3791
• Main Authors: Mahbub, M H, Yamaguchi, Natsu, Hase, Ryosuke, Takahashi, Hidekazu, Ishimaru, Yasutaka, Watanabe, Rie, Saito, Hiroyuki, Shimokawa, Junki, Yamamoto, Hiroshi, Kikuchi, Shinya, Tanabe, Tsuyoshi
• Format: Article
• Language: English
• Subjects: Adult; Amino acids; Amino Acids, Aromatic - blood; Amino Acids, Branched-Chain - blood; Biomarkers; Biomarkers - blood; Blood pressure; Case-Control Studies; Chain branching; Chains; Cross-Sectional Studies; Diabetes; Disease prevention; Female; Health care; Heart Disease Risk Factors; Humans; Hypertension; Hypertension - blood; Hypertension - epidemiology; Hypertension - etiology; Incidence; Japan - epidemiology; Laboratories; Male; Middle Aged; Pathophysiology; Physiology; Plasma; Population; Regression analysis; Risk Assessment; Trends; Variables
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu12123791

Findings of the available studies regarding the roles of branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs) in hypertension are inconsistent, conflicting and inconclusive. The purpose of this study was to explore and clarify the existence of any relationships of individual BCAAs and AAAs with hypertension with adjustments for potential relevant confounders. A total of 2805 healthy controls and 2736 hypertensive patients were included in the current analysis. The associations between individual amino acids and hypertension were explored by logistic regression analyses adjusted for potential confounding variables. Among the investigated amino acids, only the BCAAs showed consistently significant positive associations with hypertension in the adjusted models ( -trend < 0.05 to 0.001). However, compared with the corresponding lowest quartile of individual BCAAs, the positive association with hypertension remained significant only in the highest quartile ( < 0.01 to 0.001). We confirmed in a relatively large cohort of subjects that BCAAs, not AAAs, demonstrated consistent positive associations with hypertension. The results display the promising potential for the use of BCAAs as relevant and accessible biomarkers, and provide perspectives on interventions directed towards the reduction in plasma BCAA levels in the prevention and management of hypertension.